Biofourmis logo

Biofourmis Funding & Investors

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.

https://biofourmis.com/

Total Amount Raised:

Biofourmis Funding Rounds

  • Series D

    $20,000,000

    Series D Investors

    Intel Capital
  • Series D

    $300,000,000

    Series D Investors

    Openspace Ventures
    CVS Health
    EDBI
    General Atlantic
  • Series C

    $100,000,000

    Series C Investors

    Openspace Ventures
    SoftBank Investment Advisers
    EDBI
    Capikris Foundation
    MMV Europe & Asia-Pacific
    Sequoia Capital
  • Series B

    $35,000,000

    Series B Investors

    Openspace Ventures
    Peak XV Partners
    EDBI
    Aviva Ventures
    MMV Europe & Asia-Pacific
    SGInnovate
    Jianke
  • Series A

    $2,000,000

    Series A Investors

    Aviva Ventures
    SGInnovate
  • Series A

    $5,000,000

    Series A Investors

    Openspace Ventures
    Aviva Ventures
  • Seed

    $500,000

    Seed Investors

    SpesNet
  • Angel

    $1,000,000

    Angel Investors

    Eden Strategy Institute
    SpesNet
  • Angel

    100,000 SGD

    Angel Investors

    Eden Strategy Institute
Funding info provided by Diffbot.